Home » Topics » Regulatory

Regulatory
RSS

Tegoprazan approved for the treatment of GERD in Korea

July 9, 2018

No Comments

Trerief approved in Japan for additional indication

July 4, 2018

No Comments

FDA approves Braftovi + Mektovi for unresectable or metastatic melanoma

June 28, 2018

No Comments

FDA approves Zemdri for cUTI, but issues CRL for bloodstream infections

June 27, 2018

No Comments

FDA approves Epidiolex for seizures associated with LGS and Dravet syndrome

June 26, 2018

No Comments

FDA approves moxidectin to treat river blindness

June 14, 2018

No Comments

Ganovo approved in China for hepatitis C

June 13, 2018

No Comments

FDA approves Rituxan for moderate to severe pemphigus vulgaris

June 11, 2018

No Comments

FDA approves pegfilgrastim biosimilar Fulphila

June 5, 2018

No Comments

FDA approves Consensi for osteoarthritis pain and hypertension

June 4, 2018

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

Tegoprazan approved for the treatment of GERD in Korea

Trerief approved in Japan for additional indication

FDA approves Braftovi + Mektovi for unresectable or metastatic melanoma

FDA approves Zemdri for cUTI, but issues CRL for bloodstream infections

FDA approves Epidiolex for seizures associated with LGS and Dravet syndrome

FDA approves moxidectin to treat river blindness

Ganovo approved in China for hepatitis C

FDA approves Rituxan for moderate to severe pemphigus vulgaris

FDA approves pegfilgrastim biosimilar Fulphila

FDA approves Consensi for osteoarthritis pain and hypertension

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Regulatory RSS

Regulatory
RSS